Ramsey, NJ - According to Eric Strauss of NJBiz, "Ramsey-based biopharmaceutical company ADMA Biologics Inc. has added a senior vice president and two other executives to its commercialization team as it prepares to seek a license for its top immune deficiency disease product."
0 Comments
Trenton, NJ - According to NJ Business magazine, "On June 30, the NJ Economic Development Authority (EDA) announced it is accepting applications for a second group of Executives-in-Residence at the Commercialization Center for Innovative Technologies (CCIT). The program, a joint effort organized by the EDA and BioNJ, links emerging biotechnology companies with experienced mentors to help take their businesses to the next level. Applications are open to New Jersey executives with experience in business development, health economics, regulation and other areas. More information can be found here.
Summit, NJ - Celgene Corporation announced that it has entered into an agreement to purchase the Merck & Co., Inc. research and office facility located at 556 Morris Avenue in Summit, New Jersey. Pending the completion of due diligence, closing is planned for September. Financial terms of the agreement are not being disclosed.
Secaucus, NJ - EY is pleased to announce the winners of the EY Entrepreneur Of The Year® Award in New Jersey. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. The winners were selected by an independent panel of judges, and the award was presented at a special gala event at the Hyatt Regency New Brunswick on June 25.
Trenton, NJ – According to New Jersey Business Magazine, “Cybersecurity is among the greatest issues facing businesses today, and Morris Plains-based Link High Technologies recently held a seminar featuring renowned security expert Gideon Lenkey. Lenkey, the former president and Chairman of the Board of the New Jersey InfaGard Chapter, has written numerous cybersecurity publications, and was featured in the documentary film Code 2600.”
Newark, NJ - In recognition of a strong commitment to economic engagement, the Association of Public and Land-grant Universities (APLU) today designated New Jersey Institute of Technology (NJIT) in the 2015 class of Innovation & Economic Prosperity Universities. The designation acknowledges NJIT as working with public and private sector partners in New Jersey and its surrounding region to support economic development through a variety of activities, including innovation and entrepreneurship, technology transfer, talent and workforce development, and community development.
Union, NJ - According to New Jersey Business Magazine, "Kean University say its newly launched Global Business Practicum provides student consulting teams with uniquely immersive professional opportunities as they put their business skills to the test against real world challenges."
Newark, NJ - Highlighting New Jersey’s leadership as a home for innovation and the “Medicine Chest of the World,” Lt. Governor Kim Guadagno addressed the New Jersey Performing Arts Center’s (NJPAC) Business Partners “Life Sciences as an Engine of Innovation” Roundtable, presented in association with the HealthCare Institute of New Jersey (HINJ).
Philadelphia, PA – The Biotechnology Industry Organization (BIO) released “Bioscience Economic Development in the States: Legislation and Job Creation Best Practices” today at the 2015 BIO International Convention. The Best Practices Guide is the bioscience industry’s leading comprehensive analysis of state legislative and regulatory initiatives in support of economic development.
Philadelphia, PA. – The Biotechnology Industry Organization (BIO) announced its selection of New Jersey State Assemblywoman Pamela Lampitt (6th District) as a state Legislator of the Year for 2015. Assemblywoman Lampitt is the prime sponsor of A-2477, which authorizes the prescription and dispensing of biosimilar products in New Jersey. Assemblywoman Lampitt received this honor during the 2015 BIO International Convention.
Trenton, NJ - According to BioNJ, "BioNJ President and CEO Debbie Hart, along with five other New Jersey executives, including Bob Hugin, Chairman and CEO, Celgene; Sol Barer, Ph.D., Founder, Celgene, and Managing Partner, SJ Barer Consulting; Robert Hariri, M.D., Ph.D., Chairman and Founder, Celgene Cellular Therapeutics; Paul Stoffels, M.D., CSO, Johnson & Johnson; and Shirley Tilghman, Ph.D., Professor, Molecular Biology, Princeton University, were named to the Worldview 100 as six of the 100 most influential people in biotechnology."
Washington D.C. - According to Information Technology and Innovation Foundation (ITIF), "A year from now, the 2016 presidential primaries will be over, and the nominees of both parties will need to focus in earnest on the broad interests of the American people, not just the parochial concerns of their respective bases. In anticipation of that moment, ITIF has produced an open memo to all Democratic and Republican presidential campaigns outlining a comprehensive policy agenda on technology and the economy. The memo is accompanied by a draft campaign speech on fostering 21st century enterprise, which ITIF encourages candidates to borrow from freely."
Newark, NJ - Reggie J. Caudill, Ph.D., of Princeton, has been named the new dean of the School of Management (SOM) at New Jersey Institute of Technology (NJIT).
New Brunswick, NJ - Johnson & Johnson Innovation said it has launched 17 collaborations with research institutions and healthcare companies, bringing to more than 200 the total number of collaborations formed since its 2013 launch.
Trenton, NJ - Continuing its commitment to providing resources to emerging New Jersey’s life sciences companies, the New Jersey Economic Development Authority (EDA) has launched its inaugural group of Executives-in-Residence. These highly-qualified life sciences executives mentor and advise emerging technology companies at the Commercialization Center for Innovative Technologies (CCIT), the EDA’s life sciences incubator. The Executive-in-Residence program was created in collaboration with BioNJ.
|
Do not miss a single innovative moment and sign up for our newsletter!
|